Acceleron Pharma Inc.

NASDAQ: XLRN · Real-Time Price · USD
178.75
0.00 (0.00%)
At close: Apr 24, 2025, 3:47 PM

Acceleron Pharma Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q3 2021 Q2 2021 Q1 2021
Period Ending Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-70.47M -63.52M -63.47M
Depreciation & Amortization
1.16M 1.04M 1.03M
Stock-Based Compensation
11.42M 13.48M 15.63M
Other Working Capital
1.66M 1.61M 687.79M
Other Non-Cash Items
1.13M -241K 124.21M
Deferred Income Tax
n/a n/a n/a
Change in Working Capital
-14.13M -35.17M -145.31M
Operating Cash Flow
-70.89M -84.42M -67.92M
Capital Expenditures
-2.41M -969K -920K
Cash Acquisitions
n/a n/a n/a
Purchase of Investments
-26.1M -111.33M -270.14M
Sales Maturities Of Investments
85.3M 75.17M 119.85M
Other Investing Acitivies
n/a n/a n/a
Investing Cash Flow
56.79M -37.13M -151.21M
Debt Repayment
n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a
Dividend Paid
n/a n/a n/a
Other Financial Acitivies
14.15M 2.23M 3.7M
Financial Cash Flow
14.15M 2.23M 3.7M
Net Cash Flow
56K -119.31M -215.44M
Free Cash Flow
-73.3M -85.38M -68.84M